Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 First in Human Dose Escalation and Safety Study of Topical ENS-002 for Atopic Dermatitis in Adults

NCT06469385 is registered in ClinicalTrials.gov with Concerto Biosciences as lead sponsor.

NCT NCT06469385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06469385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 First in Human Dose Escalation and Safety Study of Topical ENS-002 for Atopic Dermatitis in Adults
Lead sponsor
Concerto Biosciences
Phase
Phase 1
Overall status
Terminated
Start date
September 18, 2024
Completion date
August 4, 2025
Enrollment
9 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, atopic dermatitis eczema